Business / Finance

RSS

Gecko Biomedical announces closing of Series A financing round

Gecko Biomedical, a privately owned medical device company based in Paris that is developing novel biodegradable surgical wound closure solutions, announced the closing of a €8 million ($11m) Series A financing round. The financing was co-led by Omnes Capital and CM-CIC Capital Finance, and joined by CapDecisif Management.

9 Dec 2013

NewLeaf Symbiotics announces acquisition of Intuitive Genomics

NewLeaf Symbiotics Inc. an agricultural biotech company, today announced the acquisition of Intuitive Genomics Inc., a leader in the design and implementation of custom bioinformatics solutions.

9 Dec 2013

Covidien signs definitive agreement to acquire outstanding shares of Given Imaging

Covidien plc and Given Imaging Ltd. today announced a definitive agreement under which Covidien will acquire all of the outstanding shares of Given Imaging for $30.00 per share in cash, for a total of approximately $860 million, net of cash and investments acquired. This transaction provides Covidien additional scale and scope to serve the multibillion dollar global gastrointestinal market and supports the Company's strategy to comprehensively address key global specialties and procedures.

8 Dec 2013

PhotoMedex terminates exclusive distribution agreement between Radiancy and Ya-Man in Japan

PhotoMedex, Inc. announced today the termination of the exclusive distribution agreement between its wholly-owned subsidiary Radiancy, Inc. and Ya-Man Ltd. for the Japanese market due to, among other things, disputed marketing expenses of approximately $1 million and the failure of Ya-Man to meet its minimum purchase obligations under the agreement.

6 Dec 2013

Kolltan Pharmaceuticals signs license agreement with University of Toronto for novel anti-KIT antibodies

Kolltan Pharmaceuticals, a privately held biopharmaceutical company, today announced the Company has signed a license agreement with the University of Toronto for novel anti-KIT receptor tyrosine kinase antibodies identified in the laboratories of Dr. Sachdev Sidhu at the University of Toronto and the laboratory of Dr. Joseph Schlessinger of Yale University.

6 Dec 2013

The Medicines Company, Boston Scientific announce co-promotion agreement for Promus PREMIER stent system

Boston Scientific Corporation and The Medicines Company announce a co-promotion agreement for the Boston Scientific Promus PREMIER™ Everolimus-Eluting Platinum Chromium Coronary Stent System.

6 Dec 2013

Physicians Realty Trust prices public offering of 8,300,000 common shares

Physicians Realty Trust (the "Company") today announced the pricing of its public offering of 8,300,000 common shares of beneficial interest, at a price to the public of $11.50 per share, for a total of approximately $89.4 million of net proceeds after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. All of the shares are being offered by the Company.

6 Dec 2013

Emids Technologies announces joint investment of $13.3M by Baird Capital and Council Capital

emids Technologies announced today a joint investment of $13.3 million by Baird Capital's venture capital group of Chicago and Nashville, Tenn.-based Council Capital that will enable the company to build on its leading position in the provision of healthcare IT services and solutions.

6 Dec 2013

Biocartis, VIB partner to develop novel MSI biomarkers for colorectal cancer

Today Biocartis and VIB announced their exclusive license agreement on a novel panel of microsatellite instability biomarkers for several cancers, in particular colorectal cancer.

From Biocartis 6 Dec 2013

Moberg Pharma agrees to acquire three OTC brands in the U.S. from Bayer HealthCare

Moberg Pharma AB has signed a deal to acquire three well established Over-The-Counter brands in the U.S. from Bayer HealthCare, LLC. Total annual sales for the brands are approximately 20 MSEK (ca 3 m$). The purchase price is 32 MSEK (4.8 m$) and is financed by available cash resources.

6 Dec 2013

Bostrom announces acquisition of Administrative Systems

Bostrom, a leading, national association management company, today announced its acquisition of Administrative Systems, Inc., an Illinois-based association management company. As AMCI-accredited companies, both Bostrom and ASI adhere to industry best practices. The acquisition was effective December 1.

5 Dec 2013

Alvotech to invests $250M in the development of biosimilar monoclonal antibodies

Alvotech, a powerful new player in the field of biopharmaceuticals, today announced plans to invest $250 million in the development and manufacturing of a portfolio of biosimilar monoclonal antibodies.

5 Dec 2013

Roche signs research collaboration and licensing agreement with Molecular Partners

Roche and Molecular Partners AG today announced that they have entered into a research collaboration and licensing agreement to discover, develop and commercialize several proprietary therapeutics incorporating Molecular Partners' DARPin biologics conjugated to toxic agents developed at Roche for the treatment of cancer.

4 Dec 2013

Tackling orphan diseases: an interview with Damian Marron, CEO, TxCell

The exact definition of orphan diseases varies depending on where you are in the world. In the EU it's defined as a prevalence of less than 1 in 2,000, which equates to about 250,000 patients across the EU.

4 Dec 2013

Ligand revises previous revenue and net income guidance for fourth quarter and full year 2013

Ligand Pharmaceuticals Incorporated is revising upward its previous revenue and net income guidance for the fourth quarter and full year 2013 as a result of higher-than-expected sales of Captisol® material.

4 Dec 2013

Getinge proposes to acquire Pulsion Medical Systems

Getinge intends to issue a public tender offer to acquire all shares in Pulsion Medical Systems SE ("Pulsion"), listed on the German Stock Exchange (Deutsche Börse).

4 Dec 2013

Biohit Oyj to distribute Dynex automated ELISA systems with Gastropanel

Finnish healthcare company Biohit Oyj and American company Dynex Technologies, Inc. have signed an agreement for the distribution of the two-microplate DS2®, four-microplate DSX® and 12-microplate Agility® automated ELISA (enzyme-linked immunosorbent assay) processing systems, for use with the Biohit Oyj GastroPanel.

4 Dec 2013

Takeda and Teva announce agreement related to commercialization of glatiramer acetate in Japan

Teva Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Company Limited (Takeda) today announced the signing earlier this year of an agreement in which Teva licensed to Takeda the right to commercialize Teva's innovative glatiramer acetate ( active ingredient) formulation for the treatment of multiple sclerosis, in Japan.

4 Dec 2013

Lucane Pharma, Medunik Canada to offer new therapeutic option for patients suffering from UCD

Medunik Canada, a pharmaceutical company specialized in orphan drugs and Lucane Pharma, a French niche pharmaceutical company, announced the conclusion of an exclusive collaboration agreement.

4 Dec 2013

Cell Therapeutics concludes agreement with GKV-SV regarding reimbursement price of PIXUVRI

Cell Therapeutics, Inc. (CTI) announced today that it concluded an agreement with the National Association of Statutory Health Insurance Funds (GKV-Spitzenverband) in Germany for PIXUVRI® (pixantrone).

4 Dec 2013

Business / Finance

Gecko Biomedical announces closing of Series A financing round

NewLeaf Symbiotics announces acquisition of Intuitive Genomics

Covidien signs definitive agreement to acquire outstanding shares of Given Imaging

PhotoMedex terminates exclusive distribution agreement between Radiancy and Ya-Man in Japan

Kolltan Pharmaceuticals signs license agreement with University of Toronto for novel anti-KIT antibodies

The Medicines Company, Boston Scientific announce co-promotion agreement for Promus PREMIER stent system

Physicians Realty Trust prices public offering of 8,300,000 common shares

Emids Technologies announces joint investment of $13.3M by Baird Capital and Council Capital

Biocartis, VIB partner to develop novel MSI biomarkers for colorectal cancer

Moberg Pharma agrees to acquire three OTC brands in the U.S. from Bayer HealthCare

Bostrom announces acquisition of Administrative Systems

Alvotech to invests $250M in the development of biosimilar monoclonal antibodies

Roche signs research collaboration and licensing agreement with Molecular Partners

Tackling orphan diseases: an interview with Damian Marron, CEO, TxCell

Ligand revises previous revenue and net income guidance for fourth quarter and full year 2013

Getinge proposes to acquire Pulsion Medical Systems

Biohit Oyj to distribute Dynex automated ELISA systems with Gastropanel

Takeda and Teva announce agreement related to commercialization of glatiramer acetate in Japan

Lucane Pharma, Medunik Canada to offer new therapeutic option for patients suffering from UCD

Cell Therapeutics concludes agreement with GKV-SV regarding reimbursement price of PIXUVRI

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News